Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi "San...
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Amgen to Acquire Chemocentryx for $4 Billion in Cash
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
Trevena Reports Second Quarter 2022 Results and Provides Business Update
G.CLIPS biotech is 2 years old this month!
Exscientia is 10 years old this July!
X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
Tectonic Therapeutic Strengthens Leadership Team
Addex raises $4.2 million in equity financing
Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital